# A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

> clinical trial · VERIFIED · 2026-08-17

Status: RECRUITING · Sponsor: Yuhan Corporation · Condition: NSCLC (Non-small Cell Lung Cancer)

- Company: Yuhan Corporation
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06616766

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.